Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06212934
Other study ID # LYZD202203
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date March 1, 2024
Est. completion date May 1, 2025

Study information

Verified date January 2024
Source Beijing Hospital of Traditional Chinese Medicine
Contact Huanqin Li, Doctor
Phone 0086+13521663936
Email hqin_li@163.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this clinical trial is to learn about the curative effect of "Chou's Tiaoshen" acupoints in short-term insomnia and the explore the possible mechanism of the action. The main questions it aims to answer are: - Whether the curative effect of caupuncturing"Chou's Tiaoshen" acupoints in the treatment of short-term insomnia is not inferior to that of Esazolam. - What is the possible mechanism of acupuncture "Chou's Tiaoshen"acupoints for short-term insomnia. Participants with short-term insomnia who met the criteria will be randomly assigned to "Chou's Tiaoshen"acupoints group and Esazolam group. Polysomnography, heart rate variability, cortisol and related scales will be measured before and after treatment to detect the changes in symptoms and signs before and after treatment.


Description:

The incidence of short-term insomnia is high. In clinical practice, due to patients insufficient understanding of the severity of short-term insomnia and the side effects of drug treatment, the treatment of short-term insomnia has not made breakthrough progress, and some patients may turn into chronic insomnia, which is more harmful. There is a growing consensus that short-term insomnia is a hyperarousal disorder associated with high sleep reactivity. "Chou's Tiaoshen" acupoints is derived from the experience of Zhou Dean, a national famous traditional Chinese medicine doctor in our department, and the main points are selected: Baihui (DU20), Shenting (DU24), Sishencong (EX-HN1), Shenmen (HT7), Neiguan (PC6), and Sanyinjiao (SP6), the acupuncture method has achieved good clinical efficacy in the early insomnia research, which can improve the waking state of insomnia patients during the day and improve the sleep quality at night. In order to further verify the efficacy of "Chou's Tiaoshen" acupoints in the treatment of short-term insomnia, explore the possible mechanism of action, discover the physical characteristics of patients with short-term insomnia, and explain the connotation of "Chou's Tiaoshen" acupoints, this clinical study is conducted. 96 patients with short-term insomnia who meet the inclusion criteria will be selected and divided into the "Chou's Tiaoshen" acupoints group and the oral esazolam group according to the principle of random allocation. The study will be conducted in the acupuncture and moxibustion Department of Beijing Hospital of Traditional Chinese Medicine and Shunyi Hospital of Beijing Hospital of Traditional Chinese Medicine. Pittsburgh Sleep Scale (PSQI) assessment, polysomnography (PSG, some subjects), heart rate variability (HRV) monitoring, serum cortisol measurement will be performed before and after treatment. Ford Insomnia Stress Response Test (FIRST) scale, Daytime function Scale and Chinese Medicine Symptom Score Scale will be evaluated to evaluate the efficacy and explore the mechanism.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 96
Est. completion date May 1, 2025
Est. primary completion date March 1, 2025
Accepts healthy volunteers No
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: 1. Meet diagnostic criteria for short-term insomnia according to the Diagnostic and Statistical Manual of Mental Disorders Text Revision, 5th ed (DSM-V) and Chinese Adult Insomnia Diagnosis and Treatment Guide 2017,a predominant complaint of dissatisfaction with sleep quantity or quality, associated with one (or more) of the following symptoms: 1)Difficulty initiating sleep. 2). Difficulty maintaining sleep, characterized by frequent awakenings or problems returning to sleep after awakenings. 3)Early-morning awakening with inability to return to sleep. 4)The sleep disturbance causes clinically significant distress or impairment in social, occupational, educational, academic, behavioral, or other important areas of functioning. The sleep difficulty occurs at least 3 nights per week. The duration of the sleep difficulty is 1 week to 3 months. 2. Experienced insomnia between 1 weeks and 3 months before the start of project. 3. Age: patients between 18 and 70 years old. 4. Patients who agreed to participant in this trial and assigned the informed consent. Exclusion Criteria: 1. People with other DSM-IV Axis I, Axis II mental disorders or substance abuse/dependence; 2. Patients with serious primary diseases such as cardiovascular and cerebrovascular diseases, hypertension, digestive system, hematopoietic system, liver, kidney, or severe anxiety and depression; 3. Caused by alcohol or drugs; 4. Pregnant or lactating women; 5. Easy to combine infection and bleeding; 6.1 Patients who have used psychotropic drugs, such as antidepressants, mania drugs or other drugs used to treat psychosis, in the last month, and patients who have taken sleeping pills in the last 1 month; 7. Those who cannot cooperate with treatment.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Acupuncture
"Chou's Tiaoshen" acupoints includes Baihui (GV-20), Shenting (GV-24), and Sishencong (EX-HN1), Sanyinjiao (SP-6), Shenmen (HT-7) . Using stainless steel needles (0.32×40)mm, HuaTuo, China). Then some other points like, Danzhong(CV-17), Daling(PC-7), Taixi (KI-3), Qihai (CV-6), Taichong (LR3), and Qiuxu(GB-40) are chosen. Operation: Patients in supine position. Baihui (GV-20), Shenting (GV-24), and Sishencong (EX-HN1) are punctured at a depth of 20-25mm obliquely. Sanyinjiao (SP-6) and Shenmen (HT-7) are inserted 15mm perpendicularly. Until feeling tactile sensation then manually manipulated by rotation methods to produce a characteristic sensation known as "De Qi"; Technique: Mild reinforcing and attenuating, retaining the needle for 30minutes. The treatment will be givenonce a day and 5 times a week in weekdays, the course will last two weeks.
Drug:
Estazolam
Participants will take estazolam 1mg 30min prior to bedtime everyday. The course of treatment is two weeks.

Locations

Country Name City State
China Beijing Hospital of Traditional Chinese Medicine Beijing Beijing

Sponsors (1)

Lead Sponsor Collaborator
Beijing Hospital of Traditional Chinese Medicine

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pittsburgh Sleep Quality Index The Pittsburgh Sleep Quality Index (PSQI) is a self-rated questionnaire which assesses sleep quality and disturbances. Eighteen individual items generate seven "component" scores: subjective sleep quality (SQ), sleep-onset latency (SOL), total sleep time (TST), habitual sleep efficiency (SE), sleep disturbances ( Dyssomnia), use of sleeping medication, and daytime dysfunction (DD).The cumulative component score is the PSQI total score ranging from 0 to 21, higher scores indicates worse sleep quality. PSQI will be recorded 3 times, before treatment, and at the 14th day , 28th day after treatment.
Secondary Polysomnography Polysomnography (PSG) is a classic instrument for detecting sleep conditions.The following data can be obtained by PSG monitoring: total sleep time, sleep latency, The percentage of time spent in each sleep stage. PSG is of great value for the degree and differential diagnosis of insomnia. PSG will be recorded in 10 randomly selected patients in each group before treatment and 14 days after treatment.
Secondary Heart Rate Variability (HRV) The degree and regularity of heart rate changes can be reflected by measuring the variability of continuous normal R-R interphase changes by dynamic elctrocardiogram, so as to judge its impact on cardiovascular activities, which can reflect the activity of autonomic nervous system and quantitatively evaluate the balance of sympathetic and vagal nerve tension. HRV will be recorded 3 times, before treatment, at the 14th day and 28th day after treatment.
Secondary Concentration of serum cortisol Serum cortisol is elevated during stress, which can reflect excessive arousal, and if the brain is constantly under high stress, may lead to long-term elevated cortisol levels. Serum cortisol will be recorded 2 times, before treatment, and at the 14th day , 28th day after treatment, and the measurement time was fixed at 8 am each time.
Secondary Fatigue Scale The fatigue scale(FS) consists of 14 items, each of which is a fatigue-related question, reflecting both physical fatigue and mental fatigue. The highest total score is 14 points, the lowest is 0 points, and the higher the score is, the more serious the fatigue is. FS will be recorded 3 times, before treatment, and at the 14th day , 28th day after treatment.
Secondary Ford Insomnia Response to Stress Test Chinese version,FIRST FIRST is a self-reporting tool including nine items designed to assess sleep response, The minimum total score is 9 and the maximum is 36. Higher scores on the FIRST indicate a more highly reactive sleep system. FIRST will be recorded 3 times, before treatment, and at the 14th day , 28th day after treatment.
Secondary Traditional Chinese medicine symptom scoring Scale The TCM symptom scoring scale consists of five items with a minimum score of 0 and a maximum score of 30, reflecting the five core symptoms of insomnia, with higher scores indicating more severe symptoms. TCM symptom score will be recorded 3 times, before treatment, and at the 14th day , 28th day after treatment.
See also
  Status Clinical Trial Phase
Completed NCT02671760 - Pilot Study of a Combination Drug Product for Treatment of Short-term Insomnia Phase 2